Quick Overview: Robert M. Califf, MD, Commissioner of Food and Drugs at FDA, delivers the keynote address to the 2022 Kevin Bugin, Deputy Director for Operations for the Office of New Drugs (OND) provides a background and overview of the ... The devices track will provide an overview and highlights of how to get a new medical device to market. It will also discuss some ...
Regulatory Education For Industry Redi - Detailed Overview & Context
Robert M. Califf, MD, Commissioner of Food and Drugs at FDA, delivers the keynote address to the 2022 Kevin Bugin, Deputy Director for Operations for the Office of New Drugs (OND) provides a background and overview of the ... The devices track will provide an overview and highlights of how to get a new medical device to market. It will also discuss some ... FDA experts: *Review the new BsUFA III commitments, focusing on supplement categories and associated timelines, guidance ... Content in this video provided updates and cutting-edge insight on novel artificial intelligence (AI), clinical trial designs and ... Robert M. Califf, MD, Commissioner of Food and Drugs at FDA, delivers the keynote address to the 2023
Register at to learn directly from the FDA's CAPT Connie Jung, Senior Advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR), reviews advances in ... FDA discusses considerations and best practices throughout a human drug recall life cycle including when to conduct a recall, ... FDA speakers outline the evolution and modernization of Electronic Submissions Gateway (ESG) along with plans for the next ...
